ALMAVIVA SANTÉ acquired by WREN HOUSE
Context
Wren House signed an agreement to acquire a controlling stake in Almaviva Santé from Antin Infrastructure Partners, which had initiated its exit process by mandating Rothschild & Co and Morgan Stanley as advisors following a refinancing earlier in 2021. Wren House outbid PAI Partners, which had submitted an offer, to prevail as the winning bidder. SRS, Antin's co-shareholder holding approximately 30%, will reinvest alongside Wren House. The transaction is expected to be complemented by the entry of a French institutional investor, with Bpifrance cited as a likely participant. The deal is expected to rely on an existing term loan B arranged at the time of the earlier refinancing, with no new debt raising anticipated in the near term.
ALMAVIVA SANTÉ, which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Almaviva Santé is the fourth largest private hospital group in France, operating approximately 40 establishments with strong geographic concentrations in Île-de-France — built around a network historically developed by Yves Journel — and in the Provence-Alpes-Côte d'Azur (PACA) region. The group recently expanded into Corsica through the acquisition of Maynard and its five clinics. Almaviva owns a significant real estate portfolio alongside its operational assets, which contributes meaningfully to its overall valuation.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2021 | LIVINGBRIDGE | EVERLIGHT RADIOLOGY | UNITED KINGDOM | Radiology |
| 08/2021 | COLOSSEUM DENTAL GROUP | CURAEOS | NETHERLANDS | Dental Centers |
| 07/2021 | CERBA HEALTHCARE | LIFEBRAIN | ITALY | Labs (Biology) |
| 07/2021 | EQT PARTNERS | BLIKK GROUP | GERMANY | Radiology |
| 07/2021 | EQT PARTNERS | MEINE RADIOLOGIE | GERMANY | Radiology |
| 07/2021 | OMERS | AMEDES | GERMANY | Labs (Biology) |
| 05/2021 | INFRATIL | PACIFIC RADIOLOGY GROUP | NEW ZEALAND | Radiology |
| 04/2021 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
| 04/2021 | AMERICAN SECURITIES | SIMONMED IMAGING | UNITED STATES | Radiology |
| 03/2021 | TRITON PARTNERS | BERGMAN CLINICS | NETHERLANDS | Clinics / Hospitals |
REFERENCES
Valuation range: EV 1b - 4b EUR
Revenue range: 450M - 900M EUR
EBITDA range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALMAVIVA SANTÉ by WREN HOUSE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: wren house